vs
Side-by-side financial comparison of Autolus Therapeutics plc (AUTL) and Zeo Energy Corp. (ZEO). Click either name above to swap in a different company.
Autolus Therapeutics plc is the larger business by last-quarter revenue ($21.2M vs $18.6M, roughly 1.1× Zeo Energy Corp.). Zeo Energy Corp. runs the higher net margin — -10.8% vs -373.3%, a 362.5% gap on every dollar of revenue. Zeo Energy Corp. produced more free cash flow last quarter ($2.3M vs $-72.3M).
Autolus Therapeutics plc is a clinical-stage biopharmaceutical company specializing in the development of next-generation engineered chimeric antigen receptor T-cell (CAR-T) therapies for the treatment of hematological malignancies and solid tumors. It operates in the global oncology biotech market, advancing a pipeline of targeted immunotherapy candidates across multiple clinical development stages.
AUTL vs ZEO — Head-to-Head
Income Statement — Q3 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $21.2M | $18.6M |
| Net Profit | $-79.1M | $-2.0M |
| Gross Margin | — | — |
| Operating Margin | -337.9% | -11.8% |
| Net Margin | -373.3% | -10.8% |
| Revenue YoY | — | -0.4% |
| Net Profit YoY | 3.6% | -360.9% |
| EPS (diluted) | $-0.30 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $18.6M | ||
| Q3 25 | $21.2M | $23.9M | ||
| Q2 25 | $20.9M | $18.1M | ||
| Q1 25 | $9.0M | $8.8M | ||
| Q4 24 | — | $18.6M | ||
| Q3 24 | $0 | $19.7M | ||
| Q2 24 | $0 | $14.8M | ||
| Q1 24 | $10.1M | $20.1M |
| Q4 25 | — | $-2.0M | ||
| Q3 25 | $-79.1M | $-3.2M | ||
| Q2 25 | $-47.9M | $-2.4M | ||
| Q1 25 | $-70.2M | $-6.4M | ||
| Q4 24 | — | $-435.3K | ||
| Q3 24 | $-82.1M | $-424.3K | ||
| Q2 24 | $-58.3M | $-277.8K | ||
| Q1 24 | $-52.7M | $-1.5M |
| Q4 25 | — | — | ||
| Q3 25 | — | 57.9% | ||
| Q2 25 | — | 59.8% | ||
| Q1 25 | — | 99.3% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 50.2% | ||
| Q2 24 | — | 52.3% | ||
| Q1 24 | — | — |
| Q4 25 | — | -11.8% | ||
| Q3 25 | -337.9% | -8.3% | ||
| Q2 25 | -292.6% | -15.8% | ||
| Q1 25 | -726.3% | -153.8% | ||
| Q4 24 | — | -6.0% | ||
| Q3 24 | — | -15.2% | ||
| Q2 24 | — | -18.0% | ||
| Q1 24 | -384.1% | -20.1% |
| Q4 25 | — | -10.8% | ||
| Q3 25 | -373.3% | -13.5% | ||
| Q2 25 | -229.0% | -13.3% | ||
| Q1 25 | -781.1% | -72.4% | ||
| Q4 24 | — | -2.3% | ||
| Q3 24 | — | -2.2% | ||
| Q2 24 | — | -1.9% | ||
| Q1 24 | -522.1% | -7.6% |
| Q4 25 | — | — | ||
| Q3 25 | $-0.30 | — | ||
| Q2 25 | $-0.18 | — | ||
| Q1 25 | $-0.26 | $-0.48 | ||
| Q4 24 | — | $1.11 | ||
| Q3 24 | $-0.31 | $-0.08 | ||
| Q2 24 | $-0.22 | $0.03 | ||
| Q1 24 | $-0.24 | $-1.54 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $86.1M | $6.1M |
| Total DebtLower is stronger | — | $79.1K |
| Stockholders' EquityBook value | $265.5M | $5.3M |
| Total Assets | $661.9M | $56.9M |
| Debt / EquityLower = less leverage | — | 0.01× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $6.1M | ||
| Q3 25 | $86.1M | $3.9M | ||
| Q2 25 | $123.8M | $68.7K | ||
| Q1 25 | $95.8M | $2.9M | ||
| Q4 24 | — | $5.6M | ||
| Q3 24 | $657.1M | $4.3M | ||
| Q2 24 | $705.9M | $5.3M | ||
| Q1 24 | $758.5M | — |
| Q4 25 | — | $79.1K | ||
| Q3 25 | — | $84.6K | ||
| Q2 25 | — | $642.8K | ||
| Q1 25 | — | $715.4K | ||
| Q4 24 | — | $787.7K | ||
| Q3 24 | — | $858.6K | ||
| Q2 24 | — | $1.6M | ||
| Q1 24 | — | $748.8K |
| Q4 25 | — | $5.3M | ||
| Q3 25 | $265.5M | $-1.7M | ||
| Q2 25 | $346.5M | $-59.4M | ||
| Q1 25 | $371.1M | $-23.1M | ||
| Q4 24 | — | $-88.9M | ||
| Q3 24 | $477.0M | $-39.3M | ||
| Q2 24 | $527.8M | $-53.0M | ||
| Q1 24 | $582.0M | $-173.0M |
| Q4 25 | — | $56.9M | ||
| Q3 25 | $661.9M | $58.5M | ||
| Q2 25 | $721.0M | $46.2M | ||
| Q1 25 | $746.3M | $47.4M | ||
| Q4 24 | — | $61.0M | ||
| Q3 24 | $827.5M | $47.1M | ||
| Q2 24 | $853.6M | $49.1M | ||
| Q1 24 | $901.4M | $50.1M |
| Q4 25 | — | 0.01× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-67.9M | $2.4M |
| Free Cash FlowOCF − Capex | $-72.3M | $2.3M |
| FCF MarginFCF / Revenue | -341.2% | 12.2% |
| Capex IntensityCapex / Revenue | 20.8% | 0.9% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-322.5M | $-9.9M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $2.4M | ||
| Q3 25 | $-67.9M | $-6.6M | ||
| Q2 25 | $-72.8M | $-2.3M | ||
| Q1 25 | $-75.6M | $-2.3M | ||
| Q4 24 | — | $3.5M | ||
| Q3 24 | $-76.7M | $162.2K | ||
| Q2 24 | $-51.1M | $-2.2M | ||
| Q1 24 | $-40.5M | $-10.2M |
| Q4 25 | — | $2.3M | ||
| Q3 25 | $-72.3M | $-6.8M | ||
| Q2 25 | $-80.1M | $-2.7M | ||
| Q1 25 | $-83.8M | $-2.6M | ||
| Q4 24 | — | $3.4M | ||
| Q3 24 | $-86.3M | $116.5K | ||
| Q2 24 | $-51.9M | $-2.3M | ||
| Q1 24 | $-41.0M | $-10.4M |
| Q4 25 | — | 12.2% | ||
| Q3 25 | -341.2% | -28.6% | ||
| Q2 25 | -382.6% | -15.0% | ||
| Q1 25 | -933.1% | -30.0% | ||
| Q4 24 | — | 18.2% | ||
| Q3 24 | — | 0.6% | ||
| Q2 24 | — | -15.6% | ||
| Q1 24 | -406.8% | -51.5% |
| Q4 25 | — | 0.9% | ||
| Q3 25 | 20.8% | 1.0% | ||
| Q2 25 | 34.8% | 2.4% | ||
| Q1 25 | 91.8% | 4.2% | ||
| Q4 24 | — | 0.5% | ||
| Q3 24 | — | 0.2% | ||
| Q2 24 | — | 0.7% | ||
| Q1 24 | 5.3% | 1.1% |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
AUTL
Segment breakdown not available.
ZEO
| Nonrelated Party | $18.1M | 98% |
| Related Party | $432.1K | 2% |
